Literature DB >> 26323016

Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.

Fatemeh Fattahi1, Peter A Ward2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26323016      PMCID： PMC5062739          DOI： 10.1016/j.trsl.2015.08.003

Source DB:  PubMed          Journal:  Transl Res        ISSN： 1878-1810            Impact factor:   7.012


× No keyword cloud information.
  62 in total

1.  Complement-induced impairment of innate immunity during sepsis.

Authors:  Markus S Huber-Lang; Ellen M Younkin; J Vidya Sarma; Stephanie R McGuire; Kristina T Lu; Ren Feng Guo; Vaishalee A Padgaonkar; John T Curnutte; Richard Erickson; Peter A Ward
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

Review 2.  The role of the complement system in innate immunity.

Authors:  Horea Rus; Cornelia Cudrici; Florin Niculescu
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease.

Authors:  M Prete; F Perosa; E Favoino; F Dammacco
Journal:  Clin Exp Med       Date:  2005-12       Impact factor: 3.984

Review 4.  Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms.

Authors:  Sylviane Muller; Marko Radic
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

5.  The reduced bactericidal function of complement C5-deficient murine macrophages is associated with defects in the synthesis and delivery of reactive oxygen radicals to mycobacterial phagosomes.

Authors:  D Sundarsingh Daniel; Guixiang Dai; Christopher R Singh; Devin R Lindsey; Amanda K Smith; Subramanian Dhandayuthapani; Robert L Hunter; Chinnaswamy Jagannath
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

6.  Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.

Authors:  Carlo Marchetti; Stefano Toldo; Jeremy Chojnacki; Eleonora Mezzaroma; Kai Liu; Fadi N Salloum; Andrea Nordio; Salvatore Carbone; Adolfo Gabriele Mauro; Anindita Das; Ankit A Zalavadia; Matthew S Halquist; Massimo Federici; Benjamin W Van Tassell; Shijun Zhang; Antonio Abbate
Journal:  J Cardiovasc Pharmacol       Date:  2015-07       Impact factor: 3.105

Review 7.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

8.  Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages.

Authors:  J Michelle Kahlenberg; Carmelo Carmona-Rivera; Carolyne K Smith; Mariana J Kaplan
Journal:  J Immunol       Date:  2012-12-24       Impact factor: 5.422

Review 9.  Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.

Authors:  Amit Saxena; Ilaria Russo; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2015-07-17       Impact factor: 7.012

10.  Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky; Neal S Young; Elisabetta Antonioli; Antonio M Risitano; Hubert Schrezenmeier; Jörg Schubert; Anna Gaya; Luke Coyle; Carlos de Castro; Chieh-Lin Fu; Jaroslaw P Maciejewski; Monica Bessler; Henk-André Kroon; Russell P Rother; Peter Hillmen
Journal:  Blood       Date:  2007-11-30       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.